• Call(WhatsApp Us)

    +8615360806100
  • Email Us

    cherry@laeyo.com
  • 广州市花都区花山镇华辉路18号

    微观化妆品创意产业园E栋整栋

Accelerated vs Real-Time Stability Testing for Face Creams Shipped to Saudi Arabia

Face creams are one of the harder categories to ship into Saudi Arabia. An emulsion is thermodynamically unstable by design, and a container or un-airconditioned warehouse in Jeddah or Riyadh in July can do…

Category: Skincare Sourcing Guides • Author: laeyo • Published: 2026-11-14 • Views: 24

Face creams are one of the harder categories to ship into Saudi Arabia. An emulsion is thermodynamically unstable by design, and a container or un-airconditioned warehouse in Jeddah or Riyadh in July can do in six weeks what a temperate market would take a year to reveal. The practical question for a sourcing manager is not “is the cream stable in a 25 °C lab?” but “does my shelf-life claim survive the actual route, the actual packaging, and the actual warehouse?” This guide explains what accelerated stability data can and cannot prove, how to build a real-time program that genuinely supports a shelf-life statement, and exactly what evidence to request from your manufacturer before you release a purchase order.

Why Saudi Arabia changes the stability question

Stability testing is not a formality you inherit from a formula sheet — it is the evidence base for three separate commercial commitments: the expiry date on the pack, the “no returns” clause in your distributor agreement, and the product experience your customer has in month nine.

  • Thermal load is the dominant risk. Ambient summer temperatures, container interiors during port dwell, and last-mile delivery vehicles can push a face cream well above the conditions used in a standard temperate stability study. Heat accelerates oxidation, emulsion breakdown, viscosity drift, and fragrance discoloration.
  • Regulatory route determines what you may claim. In Saudi Arabia the product should stay on the cosmetic route. The moment your marketing implies a therapeutic effect, you leave ordinary cosmetic territory and move into drug risk. That classification decision drives label wording, claim substantiation, and sometimes reformulation.
  • Humidity matters for packaging, not just the formula. Label adhesive failure, ink transfer, carton warping, and secondary packaging degradation are humidity-driven problems that a formula-only stability study will never catch.
  • Real-time data is the only thing that supports a real-time claim. Accelerated data is a screening and decision-support tool. It is not a substitute for long-term data, and it should not be mechanically extrapolated to a 36-month shelf life.

Accelerated versus real-time: what each one can actually prove

Ask your manufacturer to label every stability report by type. A report that does not state its conditions, duration, and timepoints cannot be used in a registration file or a claim defence.

Question Accelerated testing Real-time testing
What is it for? Formula screening, vendor comparison, change assessment, early red-flag detection Supporting the shelf-life statement and the on-pack expiry date
Typical conditions 40 °C / 75% RH, often plus a 45–50 °C stress arm for hot-climate routes 25 °C / 60% RH, or 30 °C / 65–75% RH for hot-climate positioning — confirm which and why
Typical duration 1–6 months 0, 3, 6, 12, 18, 24, 36 months
What it can support Go/no-go decisions, supplier change impact, packaging screening, prioritising which formula to take forward A defensible expiry date, distributor negotiations, claim substantiation, complaint investigation
What it cannot do Predict a multi-year shelf life; replace long-term data; cover real distribution abuse Move fast — it takes as long as it takes, which is why interim statements matter
Evidence deliverable Accelerated stability report marked “supportive only” Real-time stability report with raw data and trend charts against the specification limits

Add the tests that sit outside the standard panel

  • Freeze–thaw / thermal cycling: repeated cycling between low and high temperature exposes emulsion instability that a constant-temperature study hides. Three to five cycles is a practical starting point.
  • Photostability: relevant if the jar is displayed near a window, sold in open shelving, or packed in a transparent outer carton.
  • Preservative efficacy test (PET / challenge test): heat stress and consumer use patterns both change the microbial risk profile. PET is not a one-time formality — re-assess it whenever the preservative system, the water source, or a botanical raw material changes.
  • Transport simulation: vibration, drop, compression, and a port-dwell profile. Ideally aligned to a recognised transit test protocol rather than an ad hoc drop from waist height.

Build a “Golden Stability Profile” as your reference blueprint

Before any new batch is tested, lock a reference profile for each SKU. It is the benchmark every future stability result is compared against, and it prevents the classic argument where a drifting batch is judged against a re-measured baseline instead of the original target.

  • SKU and version identifiers: SKU name, formula version (e.g., F1), process version (e.g., P1).
  • T0 target: the specified value at release — for example target pH, viscosity range, appearance, and colour reference.
  • Expected trend: the normal drift you are willing to accept over shelf life. For a well-designed face cream this should be small and predictable, not “whatever the last batch did.”
  • Acceptable range: the SKU specification limits, written down and version-controlled.
  • Red flag: any out-of-specification (OOS) result, or a trend that departs materially from the expected drift. Both should trigger a documented investigation, not a quiet re-test.
  • Archived reference data: original raw data and images retained, so colour and texture comparisons are made against a fixed reference rather than memory.

The real-time program: retention samples and timepoints

The most direct evidence of long-term stability comes from retaining finished commercial batches in a controlled environment and re-testing them on a planned schedule.

  • Use a representative commercial batch (not a lab pilot) so the data reflects the actual manufacturing process.
  • Store retention samples in a controlled location with logged temperature and humidity. Warehouse shelves do not count.
  • Commit to a written timepoint plan — typically 0, 3, 6, 12, 18, 24, and 36 months — and publish it before launch so nobody can quietly drop timepoints later.
  • Test the same parameter panel at every timepoint: appearance and colour, odour, pH, viscosity, emulsion integrity (separation, phase inversion, syneresis), preservative content, microbial limits, package integrity, and any active-marker assay you rely on for claims.
  • Compare each result to the Golden Stability Profile and record the conclusion in writing — pass, trending, or OOS with investigation reference.

Saudi-specific stress add-ons

Treat the hot-climate question as a distribution question rather than a lab question. Ask your manufacturer what happens to the product at 45 °C, what happens after four thermal cycles, and what happens after three months in a container.

  • High-temperature arm: a sustained 45 °C (and ideally 50 °C) exposure over 4–12 weeks, specifically for hot-climate lanes.
  • Cold–heat cycling: simulates air freight, cold chain breaks, and ground transport in a single journey.
  • Light exposure: covers window display and open shelving.
  • Logistics note: if the formula is heat-sensitive, ask for a written high-temperature handling and shipping advisory you can pass to your freight forwarder and 3PL.

The classic complaint pattern — “the cream changed colour after it arrived in summer” — usually traces back to oxidation, pigment instability, inadequate thermal stability, or transport conditions, or a combination. The prevention set is the same: high-temperature testing, cold–heat cycling, light testing, and an explicit transport advisory. The evidence is a stability report that covers those conditions, not a reassurance email.

Packaging compatibility is a shelf-life variable, not an afterthought

Many “stability failures” are packaging failures wearing a formula costume. Lock packaging before you finalise the stability protocol, because a jar-to-airless change invalidates the previous compatibility work.

  • Dispensing and viscosity: a pump or airless system specified against an initial viscosity can fail after the formula thickens or thins at high temperature. Test dispensing at T0 and after the accelerated arm.
  • Fragrance–plastic interaction: fragrance components can soften, discolour, or stress-crack certain resins, and plasticisers can migrate into the cream. Request a compatibility report that names the resin and liner.
  • Leakage under thermal load: closures and liners behave differently at 45 °C than at 25 °C. Test inverted storage and after cycling.
  • Label adhesion and ink: humidity is the usual culprit for lifting edges and ink transfer. Ask for an adhesion check after four weeks at elevated temperature and humidity.
  • Secondary packaging: carton board strength and print durability in humid conditions.

Change control: when a supplier change forces re-testing

Raw material supplier changes are the most common hidden trigger for stability failure. A botanical extract moving from Supplier A to Supplier B is not a like-for-like swap — the chemical composition, colour body, and microbial load can all shift, which affects both chemical stability and preservative challenge.

Change scenario Typical re-assessment triggered
Botanical extract supplier change (e.g., a scalp serum or botanical face cream) Stability re-test required; PET re-assessment required; microbial specification review; shelf-life impact assessment; packaging impact assessment; decision on restarting long-term study
Preservative system or water source change PET re-test; micro specification review; accelerated stability re-run
Primary packaging change (jar to airless, new liner, new supplier) Packaging compatibility re-test; transit test; dispensing check after accelerated storage
Process or scale change (new filling line, new mixing profile) Process version update; confirmatory batch stability; T0 baseline re-lock

Action: put a contractual change-notification clause in your supply agreement. Do not cut: the re-test itself — running a new supplier’s extract through production without a stability re-test is how a two-year-old formula suddenly fails at month six. Evidence to request: a signed change-control record showing the impact assessment and the re-test protocol.

Claims guardrails for the Saudi market

Stability data and claim substantiation are connected: a claim that depends on the product remaining unchanged over shelf life needs stability evidence behind it. Review every on-pack claim against the support you actually hold.

  • “Dermatologist tested”: a dermatologist must genuinely have been involved in or supervised the relevant study. The wording must not imply that a doctor has endorsed the product’s efficacy.
  • “Clinically proven”: the study must reflect the finished product, the test population, the endpoints, and the results. Raw-material studies cannot substitute for finished-product evidence.
  • “Hypoallergenic”: a single patch test does not automatically earn this claim. It depends on the market’s expectations and needs a proper evidence file.
  • “Sensitive skin suitable”: define the target population and the test conditions clearly; do not let the claim read as a medical diagnosis.
  • “Natural” or “clean”: neither is a legal safety grade. Do not imply natural means safer.
  • “Chemical-free”: technically inaccurate and potentially misleading — remove it.
  • Anything that implies treatment: stop the ordinary cosmetic route and get specialist regulatory review before you print artwork.

Minimum evidence pack to request from your manufacturer

Copy this list into an email and send it as-is. Each line is a deliverable, not a conversation.

  • Share the formula version and process version ID for each SKU in scope.
  • Confirm the stability protocol: conditions, duration, timepoints, and parameters tested.
  • Provide the T0 baseline data for the exact batch you intend to ship.
  • Attach the real-time stability report to date — not only the accelerated report.
  • Confirm that accelerated reports are labelled as supportive evidence only.
  • Provide the high-temperature (45 °C) stress report and the cold–heat cycling report.
  • Provide the photostability report if the pack is displayed in light.
  • Provide the preservative efficacy (challenge) test report and its date.
  • Provide microbial specification and results at release and at the latest timepoint.
  • Provide the packaging compatibility report naming resin, liner, and pump specification.
  • Provide the transit and drop test report for the filled, packed shipper.
  • Provide the specification sheet with limits, and the Golden Stability Profile for each SKU.
  • Confirm the change-control position on any raw material supplier change and the re-test status.
  • Provide the claim substantiation file for every on-pack claim.
  • Provide the artwork and label review record, including the INCI list match to the COA.
  • Provide the retention sample policy, location, and temperature/humidity logs.
  • Provide the batch record and COA for the first commercial run.
  • Provide the SDS and confirm it matches the formula version on file.
  • State the proposed shelf life and the specific data set supporting it.
  • Confirm the OOS and deviation handling procedure, with a CAPA summary if applicable.
  • Confirm the next re-test date and who owns the follow-up.

Two realistic timelines

Fastest safe path (compressed, not skipped)

  • Weeks 0–2: lock packaging and formula version; approve the stability protocol and the Golden Stability Profile. Evidence: signed protocol and spec sheet.
  • Weeks 2–14: run accelerated, high-temperature, cycling, PET, micro, and packaging compatibility in parallel. Evidence: interim reports at each timepoint.
  • Weeks 8–12: pilot or first commercial batch; retain samples and start the real-time clock at T0. Evidence: batch record, COA, retention log.
  • Launch: use a conservative interim shelf-life statement supported by accelerated plus early real-time data, with a written commitment to review at 6, 12, and 24 months. Evidence: documented interim justification.

Standard path (lower risk)

  • Months 0–2: formula and packaging lock; full protocol approval; claims matrix drafted alongside the label.
  • Months 2–14: real-time study to the 12-month timepoint on at least one commercial batch, with accelerated and stress arms running in parallel.
  • Months 12–14: full documentation handoff, label review sign-off, distributor pack assembled.
  • Months 14–36: continue real-time to the 24- and 36-month timepoints; update the shelf-life statement only when the data supports it.

Common failure modes and how to prevent them

  • Discolouration or odour shift after arrival. Root cause: oxidation, pigment instability, or inadequate thermal stability combined with transport conditions. Prevention: high-temperature and cycling testing, light testing, and a written shipping advisory. Request: 45 °C stability report plus photostability data.
  • Emulsion separates at high temperature. Root cause: emulsifier system not stress-tested for the lane. Prevention: specify 45 °C and cycling arms in the protocol. Request: accelerated and cycling reports with photographs at each timepoint.
  • Pump stops dispensing or the jar leaks. Root cause: packaging selected against T0 viscosity only; pump and liner never re-tested after thermal exposure. Prevention: compatibility testing at T0 and post-accelerated storage, including inverted storage. Request: packaging compatibility report naming resin and pump model.
  • Label edges lift or ink transfers in humidity. Root cause: adhesive and ink not specified for hot-humid storage. Prevention: four-week adhesion check at elevated temperature and humidity before artwork release. Request: label supplier adhesion report.
  • Documentation failure at import or distributor onboarding. Root cause: INCI on artwork does not match the COA, or the stability, micro, or SDS file is missing or out of date. Prevention: a document lock gate before artwork approval. Request: a single indexed evidence pack tied to one formula version.
  • A claim is challenged after launch. Root cause: “dermatologist tested” or “clinically proven” used without a finished-product study or without market review. Prevention: claims matrix signed off before print. Request: the study report and the claim substantiation file.
  • Silent raw material substitution. Root cause: no change-notification clause, so a supplier swap happens between batches. Prevention: contractual notification plus mandatory re-test. Request: signed change-control record and re-test data.

Frequently asked questions

Can three months of accelerated data justify a 36-month shelf life?

No. Accelerated data is a screening and decision-support tool. It can tell you which formula to take forward and whether a change is likely to cause problems, but it should not be mechanically extrapolated into a multi-year expiry claim. The shelf-life statement needs real-time data behind it.

How long does the real-time program take before I can make a claim?

Plan on 12–36 months for a full data set, which is why interim statements matter commercially. A common approach is to launch with a conservative shelf life supported by accelerated plus early real-time data, and extend the claim only as the 12-, 24-, and 36-month timepoints report in.

Does a botanical extract supplier change require full re-testing?

Treat it as a significant change. A new supplier can alter the chemical composition and microbial load of the extract, which affects both formula stability and preservative performance. Expect a stability re-test, a preservative efficacy re-assessment, a microbial specification review, and a documented decision on whether to restart the long-term study.

What storage conditions should I specify for a hot-climate market?

For the long-term arm, 30 °C at 65–75% relative humidity is commonly used for hot-climate positioning, with 40 °C / 75% RH for the accelerated arm and a 45–50 °C stress arm for the shipping route. Ask your manufacturer to explain why they chose the conditions they propose, and make sure the justification is written into the protocol.

Does Saudi Arabia require an expiry date on cosmetics?

Requirements depend on the current regulatory framework and on your importer’s registration file, so confirm the specifics with your regulatory consultant or import partner. Regardless of the labelling requirement, holding defensible stability data protects you commercially — it is what supports your distributor terms, your returns policy, and your complaint handling.

Next step

If you are sourcing face creams for the Saudi market, the fastest way to de-risk the project is to lock the formula version, the packaging, and the stability protocol before the first production run — and to know exactly which documents you expect at handoff. Send us your target market, SKU list and formats, positioning, packaging direction, and launch timeline, and we will come back with a stability and evidence plan scoped to your route. Request a Quote.

This article is provided for general informational purposes only and does not constitute legal, regulatory, or medical advice. Confirm market-specific requirements with qualified local counsel or your regulatory consultant before making labelling or claim decisions.

Hi, I'm your LAEYO representative, hope you like this blog post.

With more than 20 years of experience in OEM/ODM/Private Label Cosmetics, I'd love to share valuable knowledge related to cosmetics & skincare products from a top-tier Chinese supplier's perspective.

  • Our team will answer your inquiries within 8 hours.
  • Your information will be kept strictly confidential.

Request received

Thanks — we’ve received your request. Our team will follow up shortly. we typically reply within 8 hours (often sooner).